GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » 3-Year Revenue Growth Rate

Vectorite Biomedical (ROCO:4170) 3-Year Revenue Growth Rate : 26.50% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical 3-Year Revenue Growth Rate?

Vectorite Biomedical's Revenue per Share for the six months ended in Dec. 2023 was NT$0.68.

During the past 12 months, Vectorite Biomedical's average Revenue per Share Growth Rate was 30.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 26.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -25.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Vectorite Biomedical was 87.50% per year. The lowest was -51.30% per year. And the median was -12.85% per year.


Competitive Comparison of Vectorite Biomedical's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Vectorite Biomedical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectorite Biomedical's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's 3-Year Revenue Growth Rate falls into.



Vectorite Biomedical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Vectorite Biomedical  (ROCO:4170) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Vectorite Biomedical 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectorite Biomedical (ROCO:4170) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines